Casdin Capital, LLC Ab Cellera Biologics Inc. Transaction History

Casdin Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$4.6 - $7.95 $735,406 - $1.27 Million	-159,871 Reduced 6.34%	2,360,129 $10.9 Million
Q1 2023 May 15, 2023	BUY	$7.31 - $11.18 $1.83 Million - $2.8 Million	250,000 Added 11.01%	2,520,000 $19 Million
Q4 2022 Feb 14, 2023	BUY	$9.48 - $14.52 $5.88 Million - $9 Million	620,000 Added 37.58%	2,270,000 $23 Million
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $8.28 Million - $12.3 Million	900,000 Added 120.0%	1,650,000 $16.3 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $4.29 Million - $7.99 Million	750,000 New	750,000 $7.99 Million
Q1 2021 May 17, 2021	SELL	$23.29 - $53.2 $4.66 Million - $10.6 Million	-200,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$39.0 - $58.9 $7.8 Million - $11.8 Million	200,000 New	200,000 $8.05 Million

155

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $807M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.